Skip to content
Clinical Trials – home

Prywatny Gabinet Lekarski Malgorzata Pawlukiewicz

Research site

Poland Ul. Staszica 17/A, 35-051 Rzeszow, Poland

  • Asthma · Chronic obstructive pulmonary disease · Cough
  • Adults and children

About Specializations

Prywatny Gabinet Lekarski Malgorzata Pawlukiewicz in Rzeszow, Poland specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, Cough, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

At this private medical office in Rzeszow, researchers focus on respiratory tract diseases, specifically evaluating new treatments for severe asthma with an eosinophilic phenotype and refractory chronic cough. The trials aim to assess long‑term safety of a biologic and the efficacy of a novel cough‑modulating drug.

  • Biologic therapy safety in eosinophilic asthma
  • Novel oral agent BLU‑5937 for chronic cough
  • Extended open‑label follow‑up
  • Patient‑reported outcome measures

The study is conducted at Prywatny Gabinet Lekarski Malgorzata Pawlukiewicz in Rzeszow, Poland, providing participants access to specialized respiratory care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Staszica 17/A35-051 RzeszowPoland
Recruiting now
no trials
Conditions studied
3

More sites in RzeszowPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Cough

Not recruiting

Study on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Camlipixant
  • Sponsor:Bellus Health Inc.

Asthma

Not recruiting

Study on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.